Form 4: ANI Pharmaceuticals Director Acquires Shares Through Restricted Stock Award
SEC Form 4 Filing
Director Jeanne Thoma acquired 4,410 shares of ANI Pharmaceuticals common stock through a restricted stock award that vests on May 21, 2025.
Summary
- Jeanne Thoma, a director of ANI Pharmaceuticals, acquired 4,410 shares of common stock on May 21, 2024.
- The acquisition was a result of a restricted stock award.
- The shares were acquired at a price of $0.
- Following the transaction, Thoma beneficially owns 40,609 shares of ANI Pharmaceuticals.
- The restricted stock award will vest in full on May 21, 2025.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 05/21/2024 | Date of transaction: Jeanne Thoma acquired 4,410 shares of ANI Pharmaceuticals common stock. |
| 05/21/2025 | Vesting date of the restricted stock award. |
| 05/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.